Amphastar Pharmaceuticals
Data Breaches, Cyber Attacks and Security Report

https://amphastar.com  ᛫  Biotech & Pharmaceuticals
Last updated November 12, 2019

About Amphastar Pharmaceuticals

Company Overview

Amphastar Pharmaceuticals is a publicly traded American speciality pharmaceutical company. It was incorporated in May 2004 and primarily develops, manufactures and sells inhalation and intranasal products.

Valuation

Employees

CEO

Jack Y. Zhang

Location

Data Breaches and Security News

Amphastar Pharmaceuticals Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Amphastar Pharmaceuticals is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Amphastar Pharmaceuticals

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Amphastar Pharmaceuticals's security performance with other companies